Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 34.27 | N/A |
| PEG Ratio (TTM) | -9.59 | N/A |
| P/S Ratio (TTM) | 0.82 | N/A |
| P/B Ratio (TTM) | 1.17 | N/A |
| P/FCF Ratio (TTM) | 15.94 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.70 | N/A |
| Price to 5YR AVG FCF Ratio | 40.94 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.90% | N/A |
| ROE (TTM) | 3.18% | N/A |
| Net Profit Margin (TTM) | 2.61% | N/A |
| ROIC 5YR AVG | 6.26% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 49.46% | -17.72% | -29.10% |
| Revenue | 2.04% | 3.58% | 8.48% |
| Net Income | 42.01% | -17.79% | -29.28% |
| Cash Flow | 23.02% | 8.69% | 388.18% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.26 | N/A |
| Quick Ratio (TTM) | 0.79 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 1.58 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.97 | N/A |
| LTL to 5YR AVG FCF | 64.68 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.16% | N/A |